Cargando…
Should the Human Microbiome Be Considered When Developing Vaccines?
Autores principales: | Ferreira, Rosana B. R., Antunes, L. Caetano M., Finlay, B. Brett |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987818/ https://www.ncbi.nlm.nih.gov/pubmed/21124987 http://dx.doi.org/10.1371/journal.ppat.1001190 |
Ejemplares similares
-
When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition
por: Littlejohn, Paula, et al.
Publicado: (2021) -
Is Genetic Mobilization Considered When Using Bacteriophages in Antimicrobial Therapy?
por: Rodríguez-Rubio, Lorena, et al.
Publicado: (2017) -
Cost and value in healthcare professional's education: should we consider a monopsony model?
por: Walsh, Kieran
Publicado: (2014) -
Unlocking the microbiome
por: Ferreira, Rosana BR, et al.
Publicado: (2023) -
Drug discovery for Chagas disease should consider Trypanosoma
cruzi strain diversity
por: Zingales, Bianca, et al.
Publicado: (2014)